Anthrax
Complement depletion renders mice sensitive to Bacillus anthracis
Published in Medical Letter on the CDC and FDA, August 28th, 2005
According to recent research published in the journal Infection and Immunity, "Concerns regarding safety and control of virulent Bacillus anthracis have created substantial hurdles to the study of anthrax. The Sterne strain is considered relatively safe to study, but this acapsular strain has a defect in normal mice and is often studied in A/J mice."
"A/J mice are highly susceptible to the Sterne strain, due to a defect in the Hc locus, which encodes complement factor 5 (C5)," said Eric T. Harvill and collaborators at the U.S. Food and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Bioterrorism
Identifying microbial pathogens in post-9/11 era reviewed - Cryptosporidiosis
Unique endemicity of cryptosporidiosis in children in Kuwait described - Enterocolitis
Necrotizing enterocolitis associated with Clostridium perfringens - Metabolic Syndrome
Mortality and diabetes risks linked to metabolic syndrome reviewed - Abdominal Aortic Aneurysms
FDA approves Powerlink trials on AAA patients with large diameter aortic necks - Adverse Drug Reaction
Importance of reporting suspected drug reactions emphasized - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
